Nature Communications (Oct 2020)
SARS-CoV-2 exposure, symptoms and seroprevalence in healthcare workers in Sweden
- Ann-Sofie Rudberg,
- Sebastian Havervall,
- Anna Månberg,
- August Jernbom Falk,
- Katherina Aguilera,
- Henry Ng,
- Lena Gabrielsson,
- Ann-Christin Salomonsson,
- Leo Hanke,
- Ben Murrell,
- Gerald McInerney,
- Jennie Olofsson,
- Eni Andersson,
- Cecilia Hellström,
- Shaghayegh Bayati,
- Sofia Bergström,
- Elisa Pin,
- Ronald Sjöberg,
- Hanna Tegel,
- My Hedhammar,
- Mia Phillipson,
- Peter Nilsson,
- Sophia Hober,
- Charlotte Thålin
Affiliations
- Ann-Sofie Rudberg
- Department of Neurology, Danderyd hospital
- Sebastian Havervall
- Division of Internal Medicine, Department of Clinical Sciences, Karolinska Institutet, Danderyd Hospital
- Anna Månberg
- Division of Affinity Proteomics, Department of Protein Science, KTH Royal Institute of Technology, SciLifeLab
- August Jernbom Falk
- Division of Affinity Proteomics, Department of Protein Science, KTH Royal Institute of Technology, SciLifeLab
- Katherina Aguilera
- Division of Internal Medicine, Department of Clinical Sciences, Karolinska Institutet, Danderyd Hospital
- Henry Ng
- Department of Medical Cell Biology, Uppsala University, SciLifeLab
- Lena Gabrielsson
- Division of Internal Medicine, Department of Clinical Sciences, Karolinska Institutet, Danderyd Hospital
- Ann-Christin Salomonsson
- Division of Internal Medicine, Department of Clinical Sciences, Karolinska Institutet, Danderyd Hospital
- Leo Hanke
- Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet
- Ben Murrell
- Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet
- Gerald McInerney
- Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet
- Jennie Olofsson
- Division of Affinity Proteomics, Department of Protein Science, KTH Royal Institute of Technology, SciLifeLab
- Eni Andersson
- Division of Affinity Proteomics, Department of Protein Science, KTH Royal Institute of Technology, SciLifeLab
- Cecilia Hellström
- Division of Affinity Proteomics, Department of Protein Science, KTH Royal Institute of Technology, SciLifeLab
- Shaghayegh Bayati
- Division of Affinity Proteomics, Department of Protein Science, KTH Royal Institute of Technology, SciLifeLab
- Sofia Bergström
- Division of Affinity Proteomics, Department of Protein Science, KTH Royal Institute of Technology, SciLifeLab
- Elisa Pin
- Division of Affinity Proteomics, Department of Protein Science, KTH Royal Institute of Technology, SciLifeLab
- Ronald Sjöberg
- Division of Affinity Proteomics, Department of Protein Science, KTH Royal Institute of Technology, SciLifeLab
- Hanna Tegel
- Division of Protein Technology, Department of Protein Science, KTH Royal Institute of Technology
- My Hedhammar
- Division of Protein Technology, Department of Protein Science, KTH Royal Institute of Technology
- Mia Phillipson
- Department of Medical Cell Biology, Uppsala University, SciLifeLab
- Peter Nilsson
- Division of Affinity Proteomics, Department of Protein Science, KTH Royal Institute of Technology, SciLifeLab
- Sophia Hober
- Division of Protein Technology, Department of Protein Science, KTH Royal Institute of Technology
- Charlotte Thålin
- Division of Internal Medicine, Department of Clinical Sciences, Karolinska Institutet, Danderyd Hospital
- DOI
- https://doi.org/10.1038/s41467-020-18848-0
- Journal volume & issue
-
Vol. 11,
no. 1
pp. 1 – 8
Abstract
Healthcare workers may be at higher risk of SARS-CoV-2 infection than the general population. Here, the authors report 19% seroprevalence of SARS-CoV-2 antibodies among 2,149 employees in a Swedish hospital. Seroprevalence was associated with patient contact and higher than the seroprevalence in the community in same time period.
